Public-domain · open source
OpenJurist
← 606 U.S. 226 - FDA v. R. J. Reynolds Vapor Co.

FDA v. R. J. Reynolds Vapor Co.’s Empirical Analysis

2025

Citation profile

2
cited by 2 later decisions
2
states following
February 2026
most recently cited

2 state decisions

Appellate journey

reviewedthe decision below (from Fifth Circuit Court of Appeals)

Relationships

Applies 15 U.S.C. § 1125 (§ 43 of the Trademark Act of 1946 (Lanham Act)) · 16 U.S.C. § 1540 (§ 11 of the Endangered Species Act of 1973) · 21 U.S.C. § 331 (Federal Food, Drug, and Cosmetic Act) · 21 U.S.C. § 387a · 21 U.S.C. § 387j · 21 U.S.C. § 387l · 28 U.S.C. § 1391 · 33 U.S.C. § 921

Relies on Allen v. Wright · Association of Data Processing Service Organizations, Inc. v. Camp · Lujan v. National Wildlife Federation · Bennett v. Spear · William Marbury v. James Madison

Most-quoted passages

The sentences later courts lift from this opinion, ranked by how many decisions quote each — the parts of the opinion doing the work. These counts are smaller than the citation total above because most of the 2 citing decisions cite the case generally; a passage count includes only decisions quoting that exact language verbatim.

  1. “there is 'no basis in text or prior practice' for limiting 'person adversely affected' to mean 'the applicant'—or, for that matter, the 'party' with whom the agency dealt.”
    1 later decision quote this exact passage · from the majority
  2. “describe a cause of action that only one person—the applicant manufacturer—could use”
    1 later decision quote this exact passage

How this case has been treated — in progress

Whether each later court followed, distinguished, criticized, or overruled this decision. The treatment classification (task #35) runs highest-cited cases first and lights up here as it reaches this one.